1 enrolling by invitation, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 1, Recruiting 1 |
Follow Lymph Node Metastasis: new trials by email Literature Review of Lymph Node Metastasis trials Research Report on Lymph Node Metastasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC propranolol, Tislelizumab, gemcitabine - Bladder Urothelial Carcinoma, Lymph Node Metastasis | Phase 1 | Enrolling by invitation | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 12 | 2026-01-01 | 2026-04-22 |
| Pilot Study of MPB-2043 Enhanced MRI for Nodal Staging in Head and Neck Squamous Cell Carcinomas MPB-2043 of 0.5 mg/kg, MPB-2043 of 1.0 mg/kg, MPB-2043 of 2.0 mg/kg - Head and Neck Squamous Cell Carcinoma, Lymph Node Metastasis | Phase 1 | Recruiting | MegaPro Biomedical Co. Ltd. | 24 | 2024-12-19 | 2025-05-08 |
Lymphatic Metastasis (2) · Squamous Cell Carcinoma of Head and Neck (1)
Neoplasm Metastasis (2) · Neoplasms (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
Cisplatin (1) · Gemcitabine (1) · Propranolol (1) · tislelizumab (1)
MegaPro Biomedical Co. Ltd. (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
China (1) · Taiwan (1)